Ennis & Ennis is dedicated to helping victims of defective and recalled traditional stents as well as the newer drug eluting stents throughout the country. If you or a loved one have been injured as a result of stent malfunction you may be entitled to compensation. For more information about your legal rights or to find out the latest recall information or for a free legal consultation contact our stent injury attorneys today.

- FDA News

10/17/2007 - An FDA advisory committee voted unanimously to recommend conditional approval for Medtronic’s Endeavor drug-eluting stent as a treatment for coronary artery disease.

If approved, the company’s zotarolimus-eluting stent would be the third drug-eluting stent available in the U.S., competing with Boston Scientific’s Taxus and Johnson & Johnson’s Cypher.

The FDA’s Circulatory System Devices Panel voted to recommend the stent for approval with conditions related to product labeling and postmarket study requirements.

If you or a loved one have been injured during surgical placement of a stent or have been injured as a result of an implanted drug eluting stent (drug coated stent) such as the Boston Scientific Taxus stent or the Johnson & Johnson Cypher stent you may be entitled to compensation. To learn more about the stent recalls, for information regarding your legal rights, or the possiblilty of a class action lawsuit contact our stent lawyers for a free, confidential, case evaluation today. Fill out our online case evaluation form or call us toll free at 1-800-856-6405.